2009
DOI: 10.1158/0008-5472.can-09-1016
|View full text |Cite
|
Sign up to set email alerts
|

WNT16B Is a New Marker of Cellular Senescence That Regulates p53 Activity and the Phosphoinositide 3-Kinase/AKT Pathway

Abstract: Senescence is a tumor suppression mechanism that is induced by several stimuli, including oncogenic signaling and telomere shortening, and controlled by the p53/p21 WAF1 signaling pathway. Recently, a critical role for secreted factors has emerged, suggesting that extracellular signals are necessary for the onset and maintenance of senescence. Conversely, factors secreted by senescent cells may promote tumor growth. By using expression profiling techniques, we searched for secreted factors that were overexpres… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
71
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(77 citation statements)
references
References 41 publications
(54 reference statements)
4
71
0
1
Order By: Relevance
“…Wnt16b was initially described as an oncogene that activated b-catenin in pre-B acute lymphoblastoid leukemia or enhanced the survival of cancer cells with or without cytotoxic therapy via a b-catenin-independent noncanonical WNT transduction pathway (37,38). Furthermore, Binet and colleagues reported Wnt16b was identified as a new marker of senescence and over-expression of Wnt16b activated the PI3K/AKT pathway (26). Consistent with previous reports, overexpression of Wnt16b in our SUP-T1-374b cells partly rescued the levels of phospho-AKT, which was suppressed by miR374b ( Supplementary Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Wnt16b was initially described as an oncogene that activated b-catenin in pre-B acute lymphoblastoid leukemia or enhanced the survival of cancer cells with or without cytotoxic therapy via a b-catenin-independent noncanonical WNT transduction pathway (37,38). Furthermore, Binet and colleagues reported Wnt16b was identified as a new marker of senescence and over-expression of Wnt16b activated the PI3K/AKT pathway (26). Consistent with previous reports, overexpression of Wnt16b in our SUP-T1-374b cells partly rescued the levels of phospho-AKT, which was suppressed by miR374b ( Supplementary Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Given that both Wnt16 and AKT1 play crucial roles in the AKT signaling pathway (26,27), the roles of miR-374b in the activation of AKT were investigated. Interestingly, the expression of phosphorylated AKT and total AKT was dramatically decreased by the restoration of miR-374b in Jurkat and SUP-T1 cells.…”
Section: Wnt16 and Akt1 Are Direct Targets Of Mir-374bmentioning
confidence: 99%
“…S4). Indeed, senescent MSCs express the others of secreted Wnts and signaling mediators that affect self-renewal and differentiation [13,29]. It has been reported that elevated Wnt5a expression in aged hematopoietic stem cells causes a shift from canonical to noncanonical Wnt signaling, thereby resulting in stem cell aging [30].…”
Section: Discussionmentioning
confidence: 99%
“…8,19 In addition to these classic markers of cellular senescence, Binet et al recently reported that Wnt16B is a marker of senescent cells. 20 Wnt16B is overexpressed in cells undergoing replicative or stress-induced senescence in vitro and those in K-Ras-induced adenomas in vivo, and forced expression of Wnt16B accelerates, whereas knockdown of Wnt16B attenuates, the onset of cellular senescence. However, because these authors failed to detect the activation of Wnt/␤-catenin signaling by Wnt16B, the link between Wnt signaling and cellular senescence is not evident in this context.…”
Section: Cellular Senescencementioning
confidence: 99%